Occlutech to pay AGA €2.1m in damages
This article was originally published in Clinica
Executive Summary
AGA Medical, a manufacturer of devices for treating structural heart defects, has won €2.1m ($2.6m) damages in its four-year dispute with German rival Occlutech. The award was the full amount which Minneapolis, Minnesota-based AGA was seeking. While the verdict is subject to appeal, AGA said it has the right to enforce the decision immediately.